Humana (NYSE:HUM) Reaches New 52-Week Low – Here’s What Happened

Humana Inc. (NYSE:HUM)’s stock price hit a new 52-week low during trading on Tuesday . The company traded as low as $181.32 and last traded at $182.1070, with a volume of 2495839 shares traded. The stock had previously closed at $189.49.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. Zacks Research cut Humana from a “hold” rating to a “strong sell” rating in a research note on Thursday, January 1st. Jefferies Financial Group lowered their target price on Humana from $313.00 to $310.00 and set a “buy” rating for the company in a report on Monday, January 26th. Barclays reissued an “underperformer” rating on shares of Humana in a research report on Monday, January 5th. Wells Fargo & Company lowered shares of Humana from an “overweight” rating to a “cautious” rating in a research note on Wednesday, January 7th. Finally, Wolfe Research raised their target price on shares of Humana from $300.00 to $325.00 and gave the company an “outperform” rating in a research report on Thursday, January 8th. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $293.21.

Humana Price Performance

The firm has a market capitalization of $21.78 billion, a P/E ratio of 16.97, a P/E/G ratio of 1.61 and a beta of 0.44. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02. The stock’s fifty day simple moving average is $250.49 and its 200 day simple moving average is $262.76.

Hedge Funds Weigh In On Humana

A number of large investors have recently made changes to their positions in HUM. New Mexico Educational Retirement Board boosted its position in shares of Humana by 7.3% in the 4th quarter. New Mexico Educational Retirement Board now owns 5,882 shares of the insurance provider’s stock worth $1,507,000 after purchasing an additional 400 shares in the last quarter. Nomura Asset Management Co. Ltd. increased its position in Humana by 5.4% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 43,920 shares of the insurance provider’s stock valued at $11,249,000 after buying an additional 2,242 shares in the last quarter. MUFG Securities EMEA plc raised its stake in Humana by 1,539.3% in the fourth quarter. MUFG Securities EMEA plc now owns 37,736 shares of the insurance provider’s stock valued at $9,665,000 after buying an additional 35,434 shares during the last quarter. Forsta AP Fonden raised its stake in Humana by 84.7% in the fourth quarter. Forsta AP Fonden now owns 48,200 shares of the insurance provider’s stock valued at $12,345,000 after buying an additional 22,100 shares during the last quarter. Finally, Norges Bank acquired a new stake in Humana in the fourth quarter worth about $456,632,000. 92.38% of the stock is owned by institutional investors and hedge funds.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.